Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Whiteside, J. B.
Right arrow Articles by Wildsmith, J. A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteside, J. B.
Right arrow Articles by Wildsmith, J. A. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2001, Vol. 86, No. 2 241-244
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia

Spinal anaesthesia with ropivacaine 5 mg ml–1 in glucose 10 mg ml–1 or 50 mg ml–1

J. B. Whiteside*, D. Burke and J. A. W. Wildsmith

University Department of Anaesthesia, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK*Corresponding author

Forty patients undergoing spinal anaesthesia for a variety of surgical procedures were randomly allocated to receive 3 ml of ropivacaine 5 mg ml–1 in glucose 10 mg ml–1 or 50 mg ml–1. Onset of sensory block to T10 was significantly faster (P=0.03) with the glucose 50 mg ml–1 solution (median 5 min, range 2–20 min) than with the 10 mg ml–1 solution (median 10 min, range 2–25 min). Maximum extent of cephalad spread was virtually the same in both groups (10 mg ml–1 median T6/7, range T3–T10; 50 mg ml–1 median T6, range T3–T10) with similar times to regression beyond S2 (10 mg ml–1 median 210 min, range 150–330 min; 50 mg ml–1 median 210 min, range 150–330 min). Complete motor block was produced in the majority of patients (10 mg ml–1 90%; 50 mg ml–1 85%) and the time to complete regression was the same in both groups (median 120 min, range 90–210 min). A block adequate for the projected surgery was achieved in all patients.

Br J Anaesth 2001; 86: 241–4


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
J. F. Luck, P. D. W. Fettes, and J. A. W. Wildsmith
Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine
Br. J. Anaesth., November 1, 2008; 101(5): 705 - 710.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Fassoulaki, V. Chatziara, A. Melemeni, M. Zotou, and C. Sarantopoulos
Preoperative Gabapentin: The Effect on Ropivacaine Subarachnoid Block and Hemodynamics
Anesth. Analg., January 1, 2008; 106(1): 334 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Contin Educ Anaesth Crit Care PainHome page
J. Whiteside and J. Wildsmith
Spinal anaesthesia: an update
CEACCP, April 1, 2005; 5(2): 37 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
P. D. W. Fettes, G. Hocking, M. K. Peterson, J. F. Luck, and J. A. W. Wildsmith
Comparison of plain and hyperbaric solutions of ropivacaine for spinal anaesthesia
Br. J. Anaesth., January 1, 2005; 94(1): 107 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
H. Kallio, E.-V. T. Snall, C. A. Tuomas, and P. H. Rosenberg
Comparison of hyperbaric and plain ropivacaine 15 mg in spinal anaesthesia for lower limb surgery
Br. J. Anaesth., November 1, 2004; 93(5): 664 - 669.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. Hocking and J. A. W. Wildsmith
Intrathecal drug spread
Br. J. Anaesth., October 1, 2004; 93(4): 568 - 578.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. A McLeod
Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine, and ropivacaine with and without dextrose
Br. J. Anaesth., April 1, 2004; 92(4): 547 - 551.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
W. Aveling, P. L. Klineberg, and J. A. W. Wildsmith
Hyperbaric ropivacaine and bupivacaine
Br. J. Anaesth., August 1, 2003; 91(2): 301 - 302.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. B. Whiteside, D. Burke, and J. A. W. Wildsmith
Comparison of ropivacaine 0.5% (in glucose 5%) with bupivacaine 0.5% (in glucose 8%) for spinal anaesthesia for elective surgery
Br. J. Anaesth., March 1, 2003; 90(3): 304 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. A. McNamee, A. M. McClelland, S. Scott, K. R. Milligan, L. Westman, and U. Gustafsson
Spinal anaesthesia: comparison of plain ropivacaine 5 mg ml-1 with bupivacaine 5 mg ml-1 for major orthopaedic surgery
Br. J. Anaesth., November 1, 2002; 89(5): 702 - 706.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
K. S. Khaw, W. D. Ngan Kee, M. Wong, F. Ng, and A. Lee
Spinal Ropivacaine for Cesarean Delivery: A Comparison of Hyperbaric and Plain Solutions
Anesth. Analg., March 1, 2002; 94(3): 680 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. B. Whiteside and J. A. W. Wildsmith
Developments in local anaesthetic drugs
Br. J. Anaesth., July 1, 2001; 87(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.